GATX:NYSEGATX Corporation Analysis
Data as of 2026-04-05 - not real-time
$174.30
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
GATX is trading at $174.3, comfortably above its 200‑day SMA (168) but still below the 50‑day SMA (180), indicating a short‑term pull‑back within a longer‑term uptrend. The MACD histogram has turned positive and the RSI sits near 52, suggesting neutral momentum with a slight bullish tilt. Valuation metrics are attractive: the trailing P/E of 19.1 is well under the industry average of 28.9 and the forward P/E of 15.6 points to earnings expansion. The dividend yield of 1.5% is supported by a modest 27% payout ratio and solid operating cash flow, despite a negative free‑cash‑flow figure. However, the balance sheet is a concern – total debt exceeds $12 billion and the debt‑to‑equity ratio is above 300%, while free cash flow remains deeply negative. Recent analyst sentiment turned cautious, highlighted by Citigroup’s downgrade to neutral, but the consensus target price of $215.5 implies a ~24% upside.
Overall, GATX offers a blend of value and growth attributes: strong margins, revenue growth of ~8½% and a sizable upside potential, tempered by leverage and cash‑flow constraints. The stock’s low beta and stable volume suggest limited market‑wide volatility, while its diversified geographic footprint mitigates regional risk. Investors should weigh the attractive valuation and dividend against the high debt load when forming a view.
Overall, GATX offers a blend of value and growth attributes: strong margins, revenue growth of ~8½% and a sizable upside potential, tempered by leverage and cash‑flow constraints. The stock’s low beta and stable volume suggest limited market‑wide volatility, while its diversified geographic footprint mitigates regional risk. Investors should weigh the attractive valuation and dividend against the high debt load when forming a view.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram and price above 200‑day SMA
- Proximity to resistance near $180
- High leverage and negative free cash flow
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to industry P/E and target price upside
- Revenue and earnings growth with solid margins
- Sustainable dividend and low payout ratio
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong operating margins and cash flow generation
- Continued dividend support
- Elevated debt burden that could limit upside
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin19.15%
P/E Ratio19.1
ROE10.97%
ROA2.25%
Debt/Equity349.83
P/B Ratio2.2
Op. Cash Flow$648.1M
Free Cash Flow$-4987049984
Industry P/E28.9
Technical Analysis
TrendNeutral
RSI51.7
Support$163.14
Resistance$180.10
MA 20$170.16
MA 50$180.46
MA 200$168.02
MACDBullish
VolumeStable
Fear & Greed Index78.8
Valuation
Target Price$215.50
Upside/Downside23.64%
GradeUndervalued
TypeBlend
Dividend Yield1.51%
Risk Assessment
Beta0.54
Volatility25.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.